Delcath to provide Chemosat system logistics, training support to Schleswig-Holstein
Delcath Systems has entered into an agreement to provide logistics and clinical training support in the performance of their hepatic Chemosat Delivery system to University Medical Center Schleswig-Holstein.
The University Medical Center Schleswig-Holstein, which provides medical care to European centers, is expected to begin training of the Chemosat system in April 2012.
University Medical Center Schleswig-Holstein Department of General and Thoracic Surgery director Thomas Becker said that their medical center will begin using Delcath's Chemosat system to treat cancers in the liver.
University Medical Center Schleswig-Holstein Axel Dermatology department professor Axel Hauschild said clinical research suggests that Chemosat will offer them a clinically significant tool in treating melanoma liver metastases with melphalan.
Related Insight
Suppliers Directory
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.